8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate

C42H55F2N5O7S2 — CID 123257992

IUPAC8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate
SMILESCC(C)CN(CC(O)C(Cc1cc(F)cc(F)c1)NC(=O)OC1C2CC3C(OCC34CCC14)O2)S(=O)(=O)c1ccc2nc(NC3CCN(C4CCCC4)CC3)sc2c1
InChIInChI=1S/C42H55F2N5O7S2/c1-24(2)21-49(58(52,53)30-7-8-33-37(19-30)57-40(46-33)45-28-10-13-48(14-11-28)29-5-3-4-6-29)22-35(50)34(17-25-15-26(43)18-27(44)16-25)47-41(51)56-38-31-9-12-42(31)23-54-39-32(42)20-36(38)55-39/h7-8,15-16,18-19,24,28-29,31-32,34-36,38-39,50H,3-6,9-14,17,20-23H2,1-2H3,(H,45,46)(H,47,51)
InChIKeyWHFLLIFCZRIIJL-UHFFFAOYSA-N
MW844.06 g/mol
LogP6.28
Rot. Bonds14

About 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate

8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate (PubChem CID 123257992) has the molecular formula C42H55F2N5O7S2 and a molecular weight of 844.06 g/mol. Its IUPAC name is 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate.

Molecular Properties

Compound Name8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate
PubChem CID123257992
Molecular FormulaC42H55F2N5O7S2
Molecular Weight844.06 g/mol
Exact Mass843.35
IUPAC Name8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate
SMILESCC(C)CN(CC(O)C(Cc1cc(F)cc(F)c1)NC(=O)OC1C2CC3C(OCC34CCC14)O2)S(=O)(=O)c1ccc2nc(NC3CCN(C4CCCC4)CC3)sc2c1
InChIInChI=1S/C42H55F2N5O7S2/c1-24(2)21-49(58(52,53)30-7-8-33-37(19-30)57-40(46-33)45-28-10-13-48(14-11-28)29-5-3-4-6-29)22-35(50)34(17-25-15-26(43)18-27(44)16-25)47-41(51)56-38-31-9-12-42(31)23-54-39-32(42)20-36(38)55-39/h7-8,15-16,18-19,24,28-29,31-32,34-36,38-39,50H,3-6,9-14,17,20-23H2,1-2H3,(H,45,46)(H,47,51)
InChIKeyWHFLLIFCZRIIJL-UHFFFAOYSA-N
XLogP6.28
TPSA142.56 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds14
Heavy Atoms58
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500844.06
LogP ≤ 56.28
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate?
The IUPAC name of 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate (CID 123257992) is 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate.
What is the SMILES notation for 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate?
The canonical SMILES for 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate is CC(C)CN(CC(O)C(Cc1cc(F)cc(F)c1)NC(=O)OC1C2CC3C(OCC34CCC14)O2)S(=O)(=O)c1ccc2nc(NC3CCN(C4CCCC4)CC3)sc2c1.
What is the InChIKey of 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate?
The InChIKey is WHFLLIFCZRIIJL-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H55F2N5O7S2/c1-24(2)21-49(58(52,53)30-7-8-33-37(19-30)57-40(46-33)45-28-10-13-48(14-11-28)29-5-3-4-6-29)22-35(50)34(17-25-15-26(43)18-27(44)16-25)47-41(51)56-38-31-9-12-42(31)23-54-39-32(42)20-36(38)55-39/h7-8,15-16,18-19,24,28-29,31-32,34-36,38-39,50H,3-6,9-14,17,20-23H2,1-2H3,(H,45,46)(H,47,51).
What are the key properties of 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate?
8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate has a molecular weight of 844.06 g/mol, XLogP of 6.28, 14 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 8,12-dioxatetracyclo[7.2.1.03,6.06,10]dodecan-2-yl N-[4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]carbamate is sourced from PubChem (CID 123257992), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).